Validation of the Freiburg Comorbidity Index in 466 Multiple Myeloma Patients and Combination With the International Staging System Are Highly Predictive for Outcome-Reference-Cited by-同舟云学术

Validation of the Freiburg Comorbidity Index in 466 Multiple Myeloma Patients and Combination With the International Staging System Are Highly Predictive for Outcome

Published:2013-10 Issue:5 Volume:13 Page:541-551
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Kleber Martina,Ihorst Gabriele,Groß Barbara,Koch Bernd,Reinhardt Heike,Wäsch Ralph,Engelhardt Monika

Funder

Deutsche Krebshilfe

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference51 articles.

1. Approach to the treatment of multiple myeloma: a clash of philosophies;Rajkumar;Blood,2011

2. Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease;Lacy;Blood,2011

3. International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation;Cavo;Blood,2011

4. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care;Fried;J Gerontol A Biol Sci Med Sci,2004

5. Multiple myeloma treatment strategies with novel agents in 2011: a European perspective;Ludwig;Oncologist,2011

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐risk multiple myeloma: Redefining genetic, clinical, and functional high‐risk disease in the era of molecular medicine and immunotherapy;American Journal of Hematology;2024-04-13

2. Disparities in Outcomes of Hospitalizations Due to Multiple Myeloma: A Nationwide Comparison;Cureus;2023-10-19

3. Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients: The TM frailty score;Frontiers in Oncology;2023-01-20

4. Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study;Journal of Geriatric Oncology;2023-01

5. Geriatric assessments and frailty scores in multiple myeloma patients: a needed tool for individualized treatment?;Current Opinion in Oncology;2021-09-16